Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Fidia Spa ( (IT:FDA) ) has provided an announcement.
Fidia S.p.A. announced that Global Growth Holding Limited has converted four bonds from the second tranche of its reserved convertible cum warrant bond loan, at a price of €0.09 per share, into 444,444 new Fidia shares. The new shares are admitted directly to trading on the regulated market under the existing prospectus, further advancing the company’s ongoing capital strengthening process.
Following this conversion, the POC bond loan has been subscribed for a nominal €500,000, and the related capital increase has reached €440,000, with six bonds still subscribed but not yet converted. As a result, Fidia’s share capital rises by €40,000 to €10,287,761.90, and the total number of shares increases to 35,076,261, modestly diluting existing shareholders while providing additional financial resources for the company’s operations and growth plans.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on Euronext Milan, is a leading developer of numerical control technology and integrated high-performance milling systems. With more than 40 years of experience and about 135 employees, the group focuses on solutions for complex shape milling, serving primarily the automotive mould sector and the aerospace industry with numerical controls, high-speed milling machines and CAM software.
Average Trading Volume: 964,804
Technical Sentiment Signal: Strong Sell
Current Market Cap: €3.3M
For an in-depth examination of FDA stock, go to TipRanks’ Overview page.